FlexiCast™ Pharma Forecasting Software
Developing evidence-based demand forecasts for the pharmaceutical industry
The industry-standard for evidence-based forecasting
FlexiCast is Inpharmation’s evidence-based pharma forecasting software, developed specifically for the challenges faced by pharmaceutical forecasting, business development and marketing teams. Inpharmation has been delivering evidence-based forecasts to the pharmaceutical industry for two decades and FlexiCast distils the evidence-based forecast principles that we have developed into a flexible and easy-to-use forecast platform.
FlexiCast is designed from the ground-up to flexibly fit into your forecast workflow. When you purchase FlexiCast you gain access to the following:
- 73 demand forecast models and tools that have been developed specifically for pharma forecasts.
- Pharma-validated peak share models that can reduce your forecast error by up to 75%*.
- Pharma-Specific™ combined forecast approaches that can reduce forecast error up to 70%**.
*Taking a combined approach vs. a standard dilution model approach.
**Based on a combination of extrapolation methods vs. an uncombined random-walk approach.
%
Reduction in peak share forecast error vs. a standard dilution approach.*
Inpharmation specializes in finding the best validated techniques and then turning them into extremely user-friendly software solutions. Purchasing FlexiCast gives you access to Pharma-Specific forecast models that have been developed over the past two decades to meet a whole range of pharmaceutical forecasting requirements. FlexiCast includes the following features and many more:
- Powerful models that determine market share for both therapy classes and brands.
- Uptake models (such as the Bass Model) that allow you to simply model the evolution of market shares for every product in one go.
- Extrapolation of stable trends using an exceptionally simple and user-friendly tool.
- Patient flow modelling that is crisp and simple and doesn’t require any specialized systems dynamics tools or training.
- Simple tools that handle all the specialist pharma issues not found in general purpose forecasting software (like co-prescription, lines of therapy, step care, oncology and other specialist markets).
- Epi-based and patient-based forecasting approaches.
- Capturing the impact of market access correctly in your forecasts.
- Simple risk modelling that does not require you to become a “Monte Carlo simulation” specialist.
%
Of top-50 pharma companies are using Inpharmation’s FlexiCast demand forecasting software.
Evidence-based pharma forecasting software
The reason 40% of the top-50 global pharma companies use Inpharmation’s evidence-based forecasting platform is because when you need accurate, reliable forecasts, you need solutions that are based upon validated, pharma-specific models and tools.
Most importantly, your pharma-specific forecasting software needs to be specific for your brand’s therapy area:
- With 73 different forecast models, FlexiCast has evidence-based forecast models that are appropriate for all main therapy areas.
- Inpharmation’s oncology-specific forecast models have been validated in the major tumor types, across EU5, US and Japan.
- Inpharmation’s core share models have been validated across 24 of the major therapeutic areas for EU5, US and Japan.
Included in all FlexiCast software licenses is software training from Inpharmation, a provider of the leading pharmaceutical executive training course with 93% satisfaction ratings.
The evidence behind Inpharmation’s fact-based approach to pricing is meticulously documented in the book Sales Forecasting for Pharmaceuticals: An Evidence-Based Approach by Inpharmation’s founder and Chairman, Gary Johnson.